dr.rsk08@gmail.com

Targeted therapy

  1. Home
  2. Services
  3. Targeted therapy
Targeted therapy

Targeted therapy is a type of cancer treatment that focuses on specific molecules involved in the growth and survival of cancer cells. Unlike traditional chemotherapy, which affects both cancer and healthy cells, targeted therapy aims to interfere with the specific pathways or molecules that contribute to the development and progression of cancer. This approach is designed to be more precise and often leads to fewer side effects. Here are key aspects of targeted therapy:

Mechanism of Action:

  1. Targeted Molecules:

    • Targeted therapy drugs are designed to target specific molecules that play a crucial role in cancer growth and progression. These molecules may include proteins, enzymes, or other factors involved in cell signaling, proliferation, and survival.

  2. Receptor Inhibition:

    • Many targeted therapies work by inhibiting the activity of receptors on the surface of cancer cells. These receptors, often proteins, receive signals that stimulate the cells to grow and divide. Targeted drugs can block these receptors, disrupting the signaling pathway and slowing down cancer cell growth.

  3. Intracellular Pathways:

    • Some targeted therapies act within the interior of cancer cells, disrupting intracellular signaling pathways. By interfering with specific molecules or enzymes inside the cells, these therapies can inhibit processes that contribute to cancer growth.

Types of Targeted Therapies:

  1. Monoclonal Antibodies:

    • These are laboratory-made molecules designed to mimic the immune system's ability to fight off cancer cells. They can be engineered to target specific proteins on the surface of cancer cells, marking them for destruction by the immune system.

  2. Tyrosine Kinase Inhibitors (TKIs):

    • These drugs block the action of enzymes called tyrosine kinases, which play a role in the growth of cancer cells. By inhibiting these enzymes, TKIs can interfere with the signaling pathways that promote cancer cell division.

  3. Hormone Therapies:

    • Hormone receptor-positive cancers, such as certain types of breast and prostate cancers, can be treated with targeted therapies that interfere with hormone signaling. This includes drugs that block estrogen or androgen receptors.

  4. Angiogenesis Inhibitors:

    • These drugs target the process of angiogenesis, which is the formation of new blood vessels that supply nutrients to cancer cells. By inhibiting angiogenesis, targeted therapies can starve the tumor of its blood supply.

Benefits of Targeted Therapy:

  1. Precision:

    • Targeted therapy is designed to specifically target cancer cells, minimizing damage to healthy cells and reducing side effects compared to traditional chemotherapy.

  2. Effective Against Specific Types of Cancer:

    • Some targeted therapies are particularly effective against specific types of cancer that have certain genetic mutations or characteristics.

  3. Complementary to Other Treatments:

    • Targeted therapy can be used in combination with other treatment modalities such as surgery, chemotherapy, and radiation therapy to enhance overall effectiveness.

Challenges and Considerations:

  1. Resistance:

    • Cancer cells may develop resistance to targeted therapies over time, leading to the need for alternative treatment strategies.

  2. Availability of Target:

    • Targeted therapy is effective only if there is a well-defined target in the cancer cells. Not all cancers have identified targets for this type of treatment.

  3. Cost and Accessibility:

    • Some targeted therapies can be expensive, and their accessibility may vary depending on factors such as healthcare systems and insurance coverage.

In summary, targeted therapy represents a promising approach in the field of cancer treatment, offering a more precise and personalized way to combat cancer by directly addressing the molecular abnormalities driving the disease. The effectiveness of targeted therapy depends on identifying specific targets within cancer cells and developing drugs that can selectively interfere with these targets.